201 related articles for article (PubMed ID: 37661995)
1. Management and outcome of locally advanced oral squamous cell carcinoma.
Bera RN; Tandon S; Singh AK; Boojar FMA; Jaiswal G; Borse S; Pal US; Sharma NK
Natl J Maxillofac Surg; 2023; 14(2):185-189. PubMed ID: 37661995
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of docetaxel, cisplatin, and concurrent radiation followed by platinum-based adjuvant chemotherapy for technically unresectable, locally advanced head and neck squamous cell carcinoma.
Nakahara S; Takenaka Y; Ogawa K; Nishiike S; Yamamoto Y; Seo Y; Isohashi F; Suzuki O; Yoshioka Y; Sumida I; Yoshii T; Tomiyama Y; Inohara H
Int J Clin Oncol; 2016 Dec; 21(6):1030-1037. PubMed ID: 27306220
[TBL] [Abstract][Full Text] [Related]
3. Can we downstage locally advanced pancreatic cancer to resectable? A phase I/II study of induction oxaliplatin and 5-FU chemoradiation.
Amodeo S; Masi A; Melis M; Ryan T; Hochster HS; Cohen DJ; Chandra A; Pachter HL; Newman E
J Gastrointest Oncol; 2018 Oct; 9(5):922-935. PubMed ID: 30505595
[TBL] [Abstract][Full Text] [Related]
4. Locally Advanced oral Squamous cell Carcinomas: Auditing and Outcome Appraisal.
Bera RN; Tripathi R; Tandon S; Adil M; Sohail S; Shashank ; Chakraborty A
Indian J Otolaryngol Head Neck Surg; 2024 Feb; 76(1):380-391. PubMed ID: 38495795
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious?
Glynne-Jones R; Grainger J; Harrison M; Ostler P; Makris A
Br J Cancer; 2006 Feb; 94(3):363-71. PubMed ID: 16465172
[TBL] [Abstract][Full Text] [Related]
6. A multicenter randomized phase II trial of hyperthermia combined with TPF induction chemotherapy compared with TPF induction chemotherapy in locally advanced resectable oral squamous cell carcinoma.
Ren G; Ju H; Wu Y; Song H; Ma X; Ge M; Qiu W; Chen Y; He Y; Zhuang Q; Meng J; Guo W
Int J Hyperthermia; 2021; 38(1):939-947. PubMed ID: 34134574
[TBL] [Abstract][Full Text] [Related]
7. Role of concomitant chemoradiation in locally advanced head and neck cancers.
Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
[TBL] [Abstract][Full Text] [Related]
8. Comparative Evaluation of Surgical Operability with and without Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.
Yelishetty H; Yadav JS; Sethi C; Chaurasia R; Singh M; Mahur S; Tripathi S; Bam B; Gupta S
Indian J Otolaryngol Head Neck Surg; 2024 Feb; 76(1):626-632. PubMed ID: 38440429
[TBL] [Abstract][Full Text] [Related]
9. Locally Advanced, Unresectable Non-Small Cell Lung Cancer.
Puri S; Saltos A; Perez B; Le X; Gray JE
Curr Oncol Rep; 2020 Mar; 22(4):31. PubMed ID: 32140986
[TBL] [Abstract][Full Text] [Related]
10. The use of topical ALA-photodynamic therapy combined with induction chemotherapy for locally advanced oral squamous cell carcinoma.
Wang X; Li N; Meng J; Wen N
Am J Otolaryngol; 2021; 42(6):103112. PubMed ID: 34214712
[TBL] [Abstract][Full Text] [Related]
11. Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.
Shaib WL; Ip A; Cardona K; Alese OB; Maithel SK; Kooby D; Landry J; El-Rayes BF
Oncologist; 2016 Feb; 21(2):178-87. PubMed ID: 26834159
[TBL] [Abstract][Full Text] [Related]
12. Definitive Surgery after Neoadjuvant Chemotherapy for Locally Advanced Oral Cavity Cancers: Experience from a Tertiary Care Center.
Agrawal M; Konduru V; Riju J; Singh A; Joel A; Karuppusami R; Tirkey AJ
South Asian J Cancer; 2023 Oct; 12(4):341-348. PubMed ID: 38130286
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for Lung Cancer-Improving Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer With Immunotherapy.
Sun L; Aggarwal C
Cancer J; 2020; 26(6):548-554. PubMed ID: 33298727
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of survival of patients with locally advanced head and neck cancer treated in a single center.
Santos FMD; Viani GA; Pavoni JF
Braz J Otorhinolaryngol; 2021; 87(1):3-10. PubMed ID: 31395491
[TBL] [Abstract][Full Text] [Related]
15. Cetuximab in the management of locoregionally advanced head and neck cancer: expanding the treatment options?
Bourhis J; Lefebvre JL; Vermorken JB
Eur J Cancer; 2010 Jul; 46(11):1979-89. PubMed ID: 20561781
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospects.
Chandana SR; Conley BA
Curr Opin Oncol; 2009 May; 21(3):218-23. PubMed ID: 19370805
[TBL] [Abstract][Full Text] [Related]
17. Strategies for non-resectable head and neck cancer.
Denaro N; Russi EG; Merlano MC
Curr Treat Options Oncol; 2013 Dec; 14(4):492-504. PubMed ID: 24065559
[TBL] [Abstract][Full Text] [Related]
18. Evolution of treatment and high-risk features in resectable locally advanced Head and Neck squamous cell carcinoma with special reference to extracapsular extension of nodal disease.
Krstevska V
J BUON; 2015; 20(4):943-53. PubMed ID: 26416042
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?
Bernier J; Cooper JS
Oncologist; 2005 Mar; 10(3):215-24. PubMed ID: 15793225
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes for patients with unresectable, locally advanced non-small-cell lung cancer treated with induction chemotherapy followed by concurrent chemoradiation vs. concurrent chemoradiation alone.
Huang EH; Liao Z; Cox JD; Guerrero TM; Chang JY; Jeter M; Borghero Y; Wei X; Fossella F; Herbst RS; Blumenschein GR; Moran C; Allen PK; Komaki R
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):779-85. PubMed ID: 17418967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
